Clinical presentation, diagnosis, and prognosis of myelodysplastic syndromes

American Journal of Medicine

Volumn 125, Issue 7 SUPPL., 2012, Pages

  Foran, James M ^a   Shammo, Jamile M ^b  

^a MAYO CLINIC   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Anemia; Cytopenias; Diagnosis; Elderly; Myelodysplastic syndromes; Specialist referral

Indexed keywords

CYCLOPHOSPHAMIDE; ENVIRONMENTAL CHEMICAL; GRANULOCYTE COLONY STIMULATING FACTOR;

BONE MARROW BIOPSY; BONE MARROW EXAMINATION; BREAST CANCER; CHEMORADIOTHERAPY; CHEMOTHERAPY; CLINICAL FEATURE; CYTOPENIA; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG MEGADOSE; DYSPLASIA; HUMAN; HYPERSPLENISM; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MACROCYTIC ANEMIA; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; PANCYTOPENIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SYMPTOMATOLOGY; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

EID: 84862868838     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2012.04.015     Document Type: Article

References (52)

1. J.M. Foran, M.A. Sekeres Myelodysplastic syndromes M.D. Abeloff, J.O. Armitage, J.E. Neiderhuber, M.B. Kastan, W.G. McKenna, Abeloff's Clinical Oncology 4th ed. 2008 Churchill Livingstone, Philadelphia 2235 2260
2. A. Barzi, M.A. Sekeres Myelodysplastic syndromes: a practical approach to diagnosis and treatment Cleve Clin J Med 77 2010 37 44
3. R. Ria, M. Moschetta, A. Reale Managing myelodysplastic symptoms in elderly patients Clin Interv Aging 4 2009 413 423
4. D.P. Steensma, J.M. Bennett The myelodysplastic syndromes: diagnosis and treatment Mayo Clin Proc 81 2006 104 130
5. E. Hellstrom-Lindberg Myelodysplastic Syndromes 2008 Remedica Publisher London
6. J. Bryan, E. Jabbour, H. Prescott, H. Kantarjian Thrombocytopenia in patients with myelodysplastic syndromes Semin Hematol 47 2010 274 280
7. H. Kantarjian, F. Giles, A. List The incidence and impact of thrombocytopenia in myelodysplastic syndromes Cancer 109 2007 1705 1714
8. N.S. Young Acquired aplastic anemia Ann Intern Med 136 2002 534 546
9. J.W. Vardiman, J. Thiele, D.A. Arber The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes Blood 114 2009 937 951
10. P. Valent, H.P. Horny, J.M. Bennett Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference Leuk Res 31 2007 727 736
11. X. Ma, M. Does, A. Raza, S.T. Mayne Myelodysplastic syndromes: incidence and survival in the United States Cancer 109 2007 1536 1542
12. D.E. Rollison, N. Howlader, M.T. Smith Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs Blood 112 2008 45 52
13. J.M. Bennett, D. Catovsky, M.T. Daniel Proposals for the classification of the myelodysplastic syndromes Br J Haematol 51 1982 189 199
14. G. Leone, L. Pagano, D. Ben-Yehuda, M.T. Voso Therapy-related leukemia and myelodysplasia: susceptibility and incidence Haematologica 92 2007 1389 1398
15. A. Josting, S. Wiedenmann, J. Franklin Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group J Clin Oncol 21 2003 3440 3446
16. R.E. Smith, J. Bryant, A. DeCillis, S. Anderson National Surgical Adjuvant Breast and Bowel Project Experience Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience J Clin Oncol. 21 2003 1195 1204
17. K. Kaito, M. Kobayashi, T. Katayama Long-term administration of G-CSF for aplastic anaemia is closely related to the early evolution of monosomy 7 MDS in adults Br J Haematol 103 1998 297 303
18. M.H. Freedman, M.A. Bonilla, C. Fier Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy Blood 96 2000 429 436
19. D. Hershman, A.I. Neugut, J.S. Jacobson Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy J Natl Cancer Inst 99 2007 196 205
20. B.P. Alter, N. Giri, S.A. Savage Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study Br J Haematol 150 2010 179 188
21. C. Aul, D.T. Bowen, Y. Yoshida Pathogenesis, etiology and epidemiology of myelodysplastic syndromes Haematologica 83 1998 71 86
22. P. Bolufer, E. Barragan, M. Collado, J. Cervera, J.A. López, M.A. Sanz Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression Leuk Res 30 2006 1471 1491
23. H. Chen, D.P. Sandler, J.A. Taylor Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect Lancet 347 1996 295 297
24. J. Christodoulou, C. Schoch, S. Schnittger, T. Haferlach Myelodysplastic syndrome (RARS) with +i(12p) abnormality in a patient 10 months after diagnosis and successful treatment of a mediastinal germ cell tumor (MGCT) Ann Hematol 83 2004 386 389
25. S.J. Corey, M.D. Minden, D.L. Barber, H. Kantarjian, J.C. Wang, A.D. Schimmer Myelodysplastic syndromes: the complexity of stem-cell diseases Nat Rev Cancer 7 2007 118 129
26. A. Tefferi, J.W. Vardiman Myelodysplastic syndromes N Engl J Med 361 2009 1872 1885
27. D.J. Grimwade, J. Stephenson, C. De Silva, R.G. Dalton, G.J. Mufti Familial MDS with 5q- abnormality Br J Haematol 84 1993 536 538
28. K. Marsden, D. Challis, R. Kimber Familial myelodysplastic syndrome with onset late in life Am J Hematol 49 1995 153 156
29. E. Maserati, A. Minelli, G. Menna Familial myelodysplastic syndromes, monosomy 7/trisomy 8, and mutator effects Cancer Genet Cytogenet 148 2004 155 158
30. S.S. Strom, Y. Gu, S.K. Gruschkus, S.A. Pierce, E.H. Estey Risk factors of myelodysplastic syndromes: a case-control study Leukemia 19 2005 1912 1918
31. P.L. Nguyen The myelodysplastic syndromes Hematol Oncol Clin North Am 23 2009 675 691
32. P. Greenberg, C. Cox, M.M. LeBeau International scoring system for evaluating prognosis in myelodysplastic syndromes Blood 89 1997 2079 2088
33. M.A. Sekeres, W.M. Schoonen, H. Kantarjian Characteristics of US patients with myelodysplastic syndromes: results of six cross-sectional physician surveys J Natl Cancer Inst 100 2008 1542 1551
34. S.K. Juneja, M. Imbert, H. Jouault, J.Y. Scoazec, F. Sigaux, C. Sultan Haematological features of primary myelodysplastic syndromes (PMDS) at initial presentation: a study of 118 cases J Clin Pathol 36 1983 1129 1135
35. J.M. Guralnik, R.S. Eisenstaedt, L. Ferrucci, H.G. Klein, R.C. Woodman Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia Blood 104 2004 2263 2268
36. J.M. Kao, A. McMillan, P.L. Greenberg International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: impact of cytopenias on clinical outcomes in myelodysplastic syndromes Am J Hematol 83 2008 765 770
37. R. Invernizzi, A. Filocco Myelodysplastic syndrome: classification and prognostic systems Oncol Rev 4 2010 25 33
38. G.J. Mufti, J.M. Bennett, J. Goasguen Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts Haematologica 93 2008 1712 1717
39. National Comprehensive Cancer Network (NCCN) NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Myelodysplastic Syndromes Version 2.2011 (2011) http://www.nccn.org/professionals/physician-gls/PDF/mds.pdf Accessed June 9, 2011
40. B.J. Bain Diagnosis from the blood smear N Engl J Med 353 2005 498 507
41. X.T. Gregg, V. Reddy, J.T. Prchal Copper deficiency masquerading as myelodysplastic syndrome Blood 100 2002 1493 1495
42. S.R. Simon, R.F. Branda, B.F. Tindle, S.L. Burns Copper deficiency and sideroblastic anemia associated with zinc ingestion Am J Hematol 28 1988 181 183
43. S.L. Goldberg, E. Chen, M. Corral Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries J Clin Oncol 28 2010 2847 2852
44. J.W. Vardiman, N.L. Harris, R.D. Brunning The World Health Organization (WHO) classification of the myeloid neoplasms Blood 100 2002 2292 2302
45. L. Malcovati, U. Germing, A. Kuendgen Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes J Clin Oncol 25 2007 3503 3510
46. H. Kantarjian, S. O'Brien, F. Ravandi Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System Cancer 113 2008 1351 1361
47. P. Greenberg, H. Tuechler, J. Schanz Revised International Prognostic Scoring System (IPSS-R), developed by the International Prognostic Working Group for Prognosis in MDS (IWG-PM) Leuk Res 35 suppl 1 2011 S6
48. L. Malcovati, M.G. Della Porta, C. Strupp Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS) Haematologica 96 2011 1433 1440
49. D. Haase, U. Germing, J. Schanz New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients Blood 110 2007 4385 4395
50. H. Van den Berghe, K. Vermaelen, C. Mecucci, D. Barbieri, G. Tricot The 5q-anomaly Cancer Genet Cytogenet 17 1985 189 255
51. J. Schanz, C. Steidl, C. Fonatsch Coalesced multicentric analysis of 2351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the International Prognostic Scoring System J Clin Oncol 29 2011 1963 1970
52. R. Bejar, K. Stevenson, O. Abdel-Wahab Clinical effect of point mutations in myelodysplastic syndromes N Engl J Med 364 2011 2496 2506